QScreen AI Deepens US Institutional Pipeline as Screening Platform Adds Escalation-Based Review Capability
Toronto, Ontario--(Newsfile Corp. - July 20, 2026) - QScreen AI Inc. (CSE: QAI) (OTC: PMEDF) (FSE: 3QP) ("QScreen" or the "Company") today announced completion of the tiered screening architecture at the core of its commercialization strategy. The architecture is fully implemented in the Company's browser-based platform and is now being demonstrated to prospective institutional partners through the Company's US channel process, where a first signed evaluation agreement remains the stated
2026-07-20 7:01 AM EDT | QScreen AI Inc.
CBIH Unveils Cannabinoid-Based Intranasal Platform for Alzheimer's Research
Houston, Texas--(Newsfile Corp. - July 20, 2026) - Alzheimer's disease is not only a scientific challenge; it is a human crisis affecting millions of patients, families, caregivers, and healthcare systems. Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) is responding through an intranasal nanoemulsion platform designed to explore new possibilities in neurodegenerative care through cannabinoid-based and natural-compound science. CBIH's invention centers on an intranasal me
Biotechnology, Pharmaceuticals, Cannabis, Health
2026-07-20 7:00 AM EDT | Cannabis Bioscience International Holdings
LevelJump Announces Revocation of Cease Trade Order; Seeking Reinstatement of Trading on TSX Venture Exchange
Toronto, Ontario--(Newsfile Corp. - July 17, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") is pleased to announce that, further to its news release of April 30, 2026, the Ontario Securities Commission has revoked a cease trade order that had been originally issued against the Company on May 6, 2026. The Company is now current on its continuous disclosure obligations under securities legislation. The Company is now in the process
Healthcare and Hospitals, Health
2026-07-17 6:55 PM EDT | LevelJump Healthcare Corp.
Charlotte Janssen Announces Resignation as Independent Director of Metaguest.AI
Toronto, Ontario--(Newsfile Corp. - July 17, 2026) - Charlotte Janssen today announced her resignation as an independent director of Metaguest.AI Incorporated, a company listed on the Canadian Securities Exchange(the "Company"), effective immediately. After careful consideration, Ms. Janssen has concluded that it is no longer appropriate to continue serving on the Company's Board of Directors due to differing views regarding certain aspects of the Board's governance processes, de
Technology, Construction / Building, Health, Legal
2026-07-17 4:42 PM EDT | Charlotte Janssen
Edison Issues Report on Theon International (THEON)
London, United Kingdom--(Newsfile Corp. - July 17, 2026) - Edison issues report on Theon International (AMS: THEON). Theon International is a leading European developer and manufacturer of customisable night vision and thermal imaging systems for military and security applications with a global footprint spanning 72 countries. Having built a leading position in man-portable night vision, the company is now broadening into platform-based optronics and digital man-portable products, suppo
Banking / Financial Services, Computer Hardware, Computer Software, Health
2026-07-17 10:58 AM EDT | Edison Group
Red Light Holland Announces Corporate Rebrand to Rhelion Life Sciences Corp
Toronto, Ontario--(Newsfile Corp. - July 17, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") is pleased to announce that it will be changing its corporate name to Rhelion Life Sciences Corp ("Rhelion"), marking
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-07-17 7:50 AM EDT | Rhelion Life Sciences Corp.
Red Light Holland Announces New Filament Health PEX010 European Research Shipment
Toronto, Ontario--(Newsfile Corp. - July 16, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland", "Red Light", or the "Company") is an Ontario based organization advancing innovation and research within the legal psychedelic sector. Following its acquisition of Filament Health Corp. ("Filament"), the Company has expanded its pharmaceutical grade manufacturing, regulatory, and clinical research capabilities, supporting the advancement of naturally derived
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-07-16 8:03 AM EDT | Rhelion Life Sciences Corp.
Adia Med Inc. (Formerly Adia Nutrition Inc.) Launches Redesigned Corporate Website
Winter Park, Florida--(Newsfile Corp. - July 15, 2026) - Adia Med Inc. (OTCQB: ADIA), a clinical-stage regenerative medicine company, today announced the launch of its redesigned corporate website. The redesigned website is now live, with the project still in progress and active changes and improvements currently being made.
Healthcare and Hospitals, Health
2026-07-15 9:30 AM EDT | Adia Med Inc.
WELL Health Closes $150 Million, 5-Year Senior Unsecured Notes Offering
Vancouver, British Columbia--(Newsfile Corp. - July 15, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, announces it has closed its previously announced inaugural private placement offering (the "Offering") of $150 million aggregate principal amount of 6.875% senior u
Technology, Computer Software, Healthcare and Hospitals, Health
2026-07-15 9:00 AM EDT | WELL Health Technologies Corp.
HarmonyRx Highlights 22 Years of Pharmacy Benefits Expertise, Building on Foundation as Broadreach Medical Research (BMR)
New York, New York--(Newsfile Corp. - July 15, 2026) - Since its founding as Broadreach Medical Research (BMR) in 2004, HarmonyRx has remained committed to transparency, clinical expertise and helping employers optimize pharmacy benefits. With more than two decades of experience in pharmacy benefits, HarmonyRx has grown alongside a rapidly changing healthcare landscape. As pharmacy costs have increased and benefit models have become more complex, the organization has remained focused on
2026-07-15 8:15 AM EDT | HarmonyRx
Extendicare Announces July 2026 Dividend of C$0.0441 per Share
Markham, Ontario--(Newsfile Corp. - July 15, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced that it has declared a cash dividend of C$0.0441 per common share of the Company for the month of July 2026, which is payable on August 17, 2026 to shareholders of record at the close of business on July 31, 2026. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare
Healthcare and Hospitals, Pharmaceuticals, Health
2026-07-15 8:00 AM EDT | Extendicare Inc.
BioHarvest Awarded $1.4M Grant from the Israel Innovation Authority to Pioneer AI-Driven Plant-Cell Synthesis
British Columbia and Rehovot, Israel--(Newsfile Corp. - July 15, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that the Israel Innovation Authority (IIA) has approved a 4.33 million NIS (approximately USD $1.4 million) grant. This non-dilutive funding will support a new research initiative at BioHar
Biotechnology, Pharmaceuticals, Health
2026-07-15 7:30 AM EDT | BioHarvest Sciences Inc.
Years of Preparation. One Regulatory Approval. Commercial Launch Begins: CBIH Receives Texas License for Consumable Hemp Products
Houston, Texas--(Newsfile Corp. - July 15, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today announced that the State of Texas has approved the Company's license to manufacture and distribute consumable hemp products. This approval turns years of vision, science, and preparation into action and marks the moment CBIH steps into the market and begins commercial distribution. The Company e
Biotechnology, Pharmaceuticals, Cannabis, Health
2026-07-15 7:00 AM EDT | Cannabis Bioscience International Holdings
Phio Pharmaceuticals Announces Patent Milestone with Multiple Notices of Allowance and Grant Decision
King of Prussia, Pennsylvania--(Newsfile Corp. - July 15, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio Pharmaceuticals announced today significant progress in the protection of its proprietary innovations across key international markets. The company has received multiple favorable patent actions encompassing three
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-07-15 7:00 AM EDT | Phio Pharmaceuticals Corp.
LevelJump Announces 2026 Q1 Financial Results
Toronto, Ontario--(Newsfile Corp. - July 14, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce its financial results for the quarter ended March 31, 2026. Financial and Operational Highlights Revenues were $4.7 million in the first quarter of 2026 compared to $4.58 million in revenues for the first quarter of 2025, a year over year revenue increase of 2.7%. Canadian Teleradiology Se
Healthcare and Hospitals, Health
2026-07-14 7:00 PM EDT | LevelJump Healthcare Corp.
LevelJump Announces 2025 Financial Results
Toronto, Ontario--(Newsfile Corp. - July 14, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce its financial results for the year ended December 31, 2025. Financial and Operational Highlights Revenues were $19.1 million in 2025 compared to $17.7 million in revenues for 2024, a year over year revenue increase of 7.9%. Canadian T
Healthcare and Hospitals, Health
2026-07-14 6:30 PM EDT | LevelJump Healthcare Corp.
AAMI Updates Standard for Manufacturers of Medtech Steam Sterilization Systems
Arlington, Virginia--(Newsfile Corp. - July 14, 2026) - The Association for the Advancement of Medical Instrumentation (AAMI) today announces the revision to its American National Standard that establishes safety and performance requirements for steam sterilization units used to process reusable medical devices in hospitals and other healthcare delivery organizations.
2026-07-14 8:55 AM EDT | Association for the Advancement of Medical Instrumentation
QScreen AI Secures Second US Patent, Extending Single-Camera Impairment Detection on Standard Hardware
Toronto, Ontario--(Newsfile Corp. - July 14, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or the "Company") now holds two granted US patents covering its core impairment-detection method, after the United States Patent and Trademark Office granted the Company US Patent No. 12,640,164, "Systems and Methods for Detecting Impairment of an Individual," on May 26, 2026. The new grant extends the Company's protection to impairment detection from a single came
2026-07-14 7:02 AM EDT | QScreen AI Inc.
TelyRx Expands Operations in Clearwater, Fla., Tripling Footprint to Meet Growing Demand for Digital Healthcare
Clearwater, Florida--(Newsfile Corp. - July 14, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a digital healthcare and online pharmacy platform, today announced a major expansion of its Clearwater headquarters and pharmacy operations, following the milestone of one million prescriptions filled and first-quarter revenue growth of 180% year-over-year. The move more than triples TelyRx's overall footprint to meet growing consumer
Healthcare and Hospitals, Health
2026-07-14 7:00 AM EDT | TelyRx
Restart Life Sciences Leverages University of Manitoba RCFTR Collaboration for Pre-Production Transition of New Protein Frameworks
Vancouver, British Columbia--(Newsfile Corp. - July 14, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to provide a strategic operational update regarding its collaboration with the Richardson Centre for Food Technology and Research (RCFTR) at the University of Manitoba. Following the recent unveiling of its newly formulated product roadmap, targeted to capitalize on emerging consumer shopping patterns, the Comp
2026-07-14 6:00 AM EDT | Restart Life Sciences Corp.